pimobendan has been researched along with Heart Disease, Ischemic in 5 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "In contrast to cyclic AMP-dependent positive inotropes, the calcium-sensitizer and partial phosphodiesterase (PDE) inhibitor pimobendan may induce beneficial effects in heart failure." | 9.07 | Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. ( Bartels, GL; de Leeuw, PW; Krauss, XH; Kruijssen, DA; Remme, WJ; Storm, CJ; van Hoogenhuyze, DC, 1994) |
| "In contrast to cyclic AMP-dependent positive inotropes, the calcium-sensitizer and partial phosphodiesterase (PDE) inhibitor pimobendan may induce beneficial effects in heart failure." | 5.07 | Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure. ( Bartels, GL; de Leeuw, PW; Krauss, XH; Kruijssen, DA; Remme, WJ; Storm, CJ; van Hoogenhuyze, DC, 1994) |
| "Pimobendan is a drug with positive inotropic effects that additionally inhibits the production of proinflammatory cytokines." | 2.42 | The role of Ca++-sensitizers for the treatment of heart failure. ( Boldt, J; Kirchner, J; Lehmann, A, 2003) |
| "Pretreatment with rolipram decreased the duration of ventricular tachycardia without any change in the incidences of dysrhythmias or the mortality rate." | 1.32 | Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat. ( Aleixandre, F; Carceles, MD; Fuente, T; Laorden, ML; López-Vidal, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carceles, MD | 1 |
| Aleixandre, F | 1 |
| Fuente, T | 1 |
| López-Vidal, J | 1 |
| Laorden, ML | 1 |
| Lehmann, A | 1 |
| Boldt, J | 1 |
| Kirchner, J | 1 |
| Hagemeijer, F | 1 |
| Remme, WJ | 1 |
| Kruijssen, DA | 1 |
| van Hoogenhuyze, DC | 1 |
| Krauss, XH | 1 |
| Bartels, GL | 1 |
| Storm, CJ | 1 |
| de Leeuw, PW | 1 |
| Abe, Y | 1 |
| Sekioka, K | 1 |
| Ishisu, R | 1 |
| Onishi, K | 1 |
| Ueda, Y | 1 |
| Nakano, T | 1 |
1 review available for pimobendan and Heart Disease, Ischemic
| Article | Year |
|---|---|
The role of Ca++-sensitizers for the treatment of heart failure.
Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; H | 2003 |
1 trial available for pimobendan and Heart Disease, Ischemic
| Article | Year |
|---|---|
Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Coronary Angiograph | 1994 |
3 other studies available for pimobendan and Heart Disease, Ischemic
| Article | Year |
|---|---|
Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Anesthesia; Animals; Arrhy | 2003 |
Hemodynamic performance during exercise in patients with severe chronic congestive heart failure before and after a single dose of pimobendan.
Topics: Administration, Oral; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Exercise; Female; He | 1994 |
Restoration of ischemic contractile failure of indo-1-loaded guinea pig heart by a calcium sensitizer, MCI-154.
Topics: Animals; Calcium; Cardiotonic Agents; Guinea Pigs; Indoles; Male; Myocardial Contraction; Myocardial | 1996 |